Medigen Biotechnology (3176) — Free Cash Flow Generation Index
Medigen Biotechnology (3176) has a Free Cash Flow Generation Index of 0.94x as of December 2024. Free cash flow of NT$147.66 Million represents 1% of operating cash flow (NT$156.75 Million). Read Medigen Biotechnology debt and liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Medigen Biotechnology Free Cash Flow Generation Index (2003–2024)
Historical FCF Generation Index trend for Medigen Biotechnology across 5 annual periods. Explore Medigen Biotechnology capex to cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Medigen Biotechnology (2003–2024)
Year-by-year Free Cash Flow Generation Index for Medigen Biotechnology. For the full company profile including market capitalisation, see Medigen Biotechnology (3176) market capitalisation.
| Year | FCG Index | Free Cash Flow (TWD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.55x | NT$-20.76 Million | NT$37.92 Million | NT$58.68 Million | ▼ -176.0% |
| 2021 | 0.72x | NT$372.90 Million | NT$517.45 Million | NT$144.55 Million | ▼ -73.8% |
| 2015 | 2.75x | NT$809.42 Million | NT$294.18 Million | NT$515.25 Million | ▲ +164.6% |
| 2005 | 1.04x | NT$83.93 Million | NT$80.72 Million | NT$3.21 Million | ▲ +3.1% |
| 2003 | 1.01x | NT$449.42 Million | NT$445.46 Million | NT$3.96 Million | — |